Switch to:
More From Other Websites
Multiple FDA-Cleared Devices Give This Company Extraordinary Upside Dec 03 2014
NEURALSTEM, INC. Files SEC form 8-K, Other Events Nov 17 2014
Neuralstem NSI-189 Phase Ib Major Depression Disorder Neurogenic Biomarker Data Presented At The CNS... Nov 17 2014
NEURALSTEM, INC. Financials Nov 15 2014
10-Q for Neuralstem, Inc. Nov 10 2014
NEURALSTEM, INC. Files SEC form 8-K, Other Events Nov 10 2014
Neuralstem Announces Publication Of Long Term Cell Survival From Phase I NSI-566 ALS Study In The... Nov 10 2014
NEURALSTEM, INC. Files SEC form 8-K, Results of Operations and Financial Condition Nov 07 2014
Neuralstem Among Our 'Best for 2015' Biotech Names Nov 07 2014
Neuralstem posts 3Q loss Nov 07 2014
Neuralstem posts 3Q loss Nov 07 2014
Neuralstem Reports Third Quarter Financial Results And Provides Business And Clinical Update Nov 07 2014
NEURALSTEM, INC. Files SEC form 10-Q, Quarterly Report Nov 07 2014
NEURALSTEM, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a... Oct 29 2014
NEURALSTEM, INC. Files SEC form 8-K, Other Events Oct 23 2014
Neuralstem Alzheimer's Disease Animal Data Presented At The Congress Of Neurological Surgeons Annual... Oct 23 2014
NEURALSTEM, INC. Files SEC form 8-K, Other Events Oct 09 2014
First Patient Treated In Neuralstem Phase I Spinal Cord Injury Stem Cell Trial Through The UC San... Oct 09 2014
NEURALSTEM, INC. Files SEC form 8-K, Other Events Sep 22 2014
Neuralstem ALS Investigator Presents Long-Term Follow Up Phase I Data Sep 22 2014

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK